Related Experiment Video

Updated: May 23, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

[The impact of dysglycemia on brain function in children with type 1 diabetes mellitus]

Ewa Pańkowska1

  • 1Poradnia Diabetologiczna, Instytut Matki i Dziecka, Warszawa. ewa.pankowska@imid.med.pl

Medycyna Wieku Rozwojowego
|April 21, 2012
PubMed

Insights

Type 1 diabetes (T1DM) management with insulin can cause blood sugar fluctuations (dysglycemia) and lead to central nervous system (CNS) damage. Further research is needed to understand metabolic and morphological CNS changes in children with T1DM.

Area of Science:

  • Endocrinology
  • Neurology
  • Metabolic Diseases

Context:

  • Type 1 diabetes mellitus (T1DM) requires mandatory insulin therapy.
  • Insulin therapy can lead to dysglycemia (hyperglycemia and hypoglycemia).
  • T1DM is associated with long-term organ damage, including retinopathy, nephropathy, and neuropathy.

Purpose:

  • To highlight the potential for central nervous system (CNS) damage in children with T1DM.
  • To emphasize the need for further research into the structural and functional CNS changes in pediatric T1DM.
  • To explore the link between metabolic control and CNS alterations.

Summary:

  • T1DM, a metabolic disorder, necessitates insulin therapy which can cause blood glucose instability.
  • Diabetic complications like retinopathy, nephropathy, and neuropathy are linked to T1DM.
  • Studies indicate metabolic and morphological CNS changes in children with T1DM result from both hypo- and hyperglycemia, with observed links to epilepsy, abnormal EEG, and cognitive impairment in adults diagnosed in childhood.

Impact:

  • Underscores the critical need for comprehensive understanding and management of T1DM beyond glycemic control.
  • Highlights the potential long-term neurological consequences of T1DM in pediatric populations.
  • Informs future research directions for mitigating CNS complications in T1DM.

More Related Videos

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish05:49

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish

Published on: May 5, 2021

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats07:41

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...